1. McGill JB, Hirsch IB, Parkin CG, Aleppo G, Levy CJ, Gavin JR 3rd. The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review. Diabetes Ther. 2024. 15(5):1085-1098. doi: 10.1007/s13300-024-01569-8.
2. Donnor T, Sarkar S. Insulin- Pharmacology, Therapeutic Regimens and Principles of Intensive Insulin Therapy. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2023. https://www.ncbi.nlm.nih.gov/books/NBK278938/
3. American Diabetes Association Professional Practice Committee; 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025. Diabetes Care, 2025. 48 (Supplement_1): S181–S206. https://doi.org/10.2337/dc25-S009
4. Galdón Sanz-Pastor A, Justel Enríquez A, Sánchez Bao A, Ampudia-Blasco FJ. Current barriers to initiating insulin therapy in individuals with type 2 diabetes. Front Endocrinol (Lausanne). 2024.15:1366368. doi: 10.3389/fendo.2024.1366368.
5. Bin Rsheed A, Chenoweth I. Barriers that practitioners face when initiating insulin therapy in general practice settings and how they can be overcome. World J Diabetes. 2017 Jan 15;8(1):28-39. doi: 10.4239/wjd.v8.i1.28.
6. Ali A, Cheng AY, Yu CH. Breaking down barriers to initiating insulin: Insulin prescription pad. Can Fam Physician. 2015 May;61(5):445-7.
7. Brod M, Alolga SL, Meneghini L. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient. 2014;7(4):437-50. doi: 10.1007/s40271-014-0068-x.
8. Chen R, Aamir AH, Feroz Amin M, et al. Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia-Pacific Region. Diabetes Ther. 2024 Jun;15(6):1261-1277. doi: 10.1007/s13300-024-01568-9.
9. Shafie Pour MR, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R. The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran. Diabetes Metab Syndr Obes. 2019 Aug 7;12:1349-1354. doi: 10.2147/DMSO.S200867.
10. Badan Pengawas Obat Dan Makanan. Pengawasan Obat Dan Makanan Yang Diedarkan Secara Daring. 2024. https://standar-otskk.pom.go.id/storage/uploads/476ae6a1-d061-4271-bdc8-d716b9bd24cd/PerBPOM-No.-14-tahun-2024.pdf
11. American Diabetes Association Professional Practice Committee; 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025. Diabetes Care, 2025, 48 (Supplement_1): S128–S145. https://doi.org/10.2337/dc25-S006
12. American Diabetes Association Professional Practice Committee; 7. Diabetes Technology: Standards of Care in Diabetes—2025. Diabetes Care, 2025. 48 (Supplement_1): S146–S166. https://doi.org/10.2337/dc25-S007
13. Mary L. Johnson, Richard M. Bergenstal, Brian L. Levy, Darlene M. Dreon; A Safe and Simple Algorithm for Adding and Adjusting Mealtime Insulin to Basal-Only Therapy. Clin Diabetes, 2022. 40 (4): 489–497. https://doi.org/10.2337/cd21-0137
14. Chan SP, Aamir AH, Bee YM, et al. Practical Guidance on Basal Insulin Initiation and Titration in Asia: A Delphi-Based Consensus. Diabetes Ther. 2022 Aug;13(8):1511-1529. doi: 10.1007/s13300-022-01286-0
15. Mehta R, Goldenberg R, Katselnik D, Kuritzky L. Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care. Ann Med. 2021 Dec;53(1):998-1009. doi: 10.1080/07853890.2021.1925148.
16. American Diabetes Association. Insulin Pens. 2025. https://diabetes.org/about-diabetes/devices-technology/insulin-pens
17. PERKENI. Petunjuk Praktis Terapi Insulin pada Pasien Diabetes Mellitus. 2021. https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-_-Website-Pedoman-Petunjuk-Praktis-Terapi-Insulin-Pada-Pasien-Diabetes-Mellitus-Ebook.pdf
18. Tanaka R, Watanabe S. Skin disinfection using hygiene swabs for self-injection of diabetes medications: an overview of the current best practices. Diabetol Int. 2022 Dec 16;14(2):115-116. doi: 10.1007/s13340-022-00615-9
19. ASHP. Insulin Glargine. 2025. https://www.drugs.com/monograph/insulin-glargine.html
20. Lowe RN, Williams B, Claus LW. Diabetes: how to manage patients experiencing hypoglycaemia. Drugs Context. 2022 Jun 14;11:2021-9-11. doi: 10.7573/dic.2021-9-11.
21. Akinci B, Gular MC, Oral EA. Lipodystrophy Syndromes: Presentation and Treatment.. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2024. https://www.ncbi.nlm.nih.gov/books/NBK513130/
22. Tsadik AG, Atey TM, Nedi T, Fantahun B, Feyissa M. Effect of Insulin-Induced Lipodystrophy on Glycemic Control among Children and Adolescents with Diabetes in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. J Diabetes Res. 2018 Jul 4;2018:4910962. doi: 10.1155/2018/4910962.
23. Altun İ. May the Z-Tracking Technique to Prevent Any Leakage in Insulin Injection Be an Alternative to the 10-Second Waiting Technique? J Diabetes Sci Technol. 2018 Mar;12(2):537-538. doi: 10.1177/1932296817730378.
24. Home P, Riddle M, Cefalu WT, Bailey CJ, Bretzel RG, Del Prato S, Leroith D, Schernthaner G, van Gaal L, Raz I. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes Care. 2014 Jun;37(6):1499-508. doi: 10.2337/dc13-2743.
25. Vos RC, van Avendonk MJP, Jansen H, et al. Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No.: CD006992. DOI: 10.1002/14651858.CD006992.pub2.
26. Chen YH, Li HZ, Tang ZS, Xu L, Wang H, Feng B. Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin. Diabetes Ther. 2019. 10(2):463-471. doi: 10.1007/s13300-019-0564-z.